XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > DELISTED on TSX.V and Nasdaq

<< Previous

Bullboard Posts

Next >>

Comment by Anklebiter42on Nov 05, 2021 6:56pm

108 Views

Post# 34094647

RE:DELISTED on TSX.V and Nasdaq

XORTX is ALIVE and WELL. Good work Spacelab on your sentence structure and grammar. Hooked on phonics seems to be working for you. Maybe you could now enrol in a computer class. BAHAHAHA!!!! It would be good timing for you to find another stock to bash.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec